Status:
COMPLETED
Replaceability of Fluoroscopy and Ultrasound in the Evaluation of Hemidiaphragm Excursion
Lead Sponsor:
University of Aarhus
Conditions:
Diaphragm Disease
Eligibility:
All Genders
18+ years
Brief Summary
Precise measurement of diaphragm function is difficult. Several methods exist. No are sufficiently validated. With this study, the investigators wish to investigate the validity of different ultrasou...
Detailed Description
Fluoroscopy assessment of diaphragm motility is obtained and simultaneously correlated to sonographic assessments of motility.
Eligibility Criteria
Inclusion
- Completed informed consent
- one of the following conditions:
- Healthy participants, control group
- Lung disease group.
- COPD or
- Ideopatic pulmonary fibrosis.
- Heart disease group.
- Heart disease that lead to:
- heart transplantat or
- left ventricular assist device.
Exclusion
- Known diaphragm dysfunction.
- Neuromuscular disease.
- Pleural effusion.
- Pneumothorax.
- In the healthy group: Significant comorbidity that affect heart og lung function (arterial hypertention, mild valve disease and COPD without symptoms are accepted).
- In the healthy group and in the lung disease group: Previous thorax surgery.
Key Trial Info
Start Date :
May 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2021
Estimated Enrollment :
42 Patients enrolled
Trial Details
Trial ID
NCT04098939
Start Date
May 1 2020
End Date
December 31 2021
Last Update
December 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Søren Helbo Skaarup
Aarhus, Denmark, 8200